How should treatment decisions be made for incapacitated patients, and why?
PLoS Med
.
2007 Mar;4(3):e35.
doi: 10.1371/journal.pmed.0040035.
Authors
David I Shalowitz
1
,
Elizabeth Garrett-Mayer
,
David Wendler
Affiliation
1
National Institutes of Health Department of Clinical Bioethics, National Institutes of Health Clinical Center, Bethesda, Maryland, United States of America.
PMID:
17388655
PMCID:
PMC1820603
DOI:
10.1371/journal.pmed.0040035
No abstract available
MeSH terms
Advance Directives
Decision Making
Demography
Humans
Mental Competency*
Third-Party Consent*
Treatment Outcome
United States